Trimethoprim: Clinical Use and Pharmacokinetics
- 1 May 1981
- journal article
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 15 (5) , 325-330
- https://doi.org/10.1177/106002808101500502
Abstract
The recent marketing of trimethoprim (TMP) as a single drug has resulted in interest in the use of this drug to treat common infections. The history and antibacterial properties of TMP are reviewed. Indications for the clinical use of TMP are presented, and possible new uses for the drug are considered. The significance of adverse effects is discussed. The pharmacokinetic properties of TMP are reviewed with particular emphasis on the renal handling of the drug and its advantages over TMP/sulfonamide combinations in relation to renal function and toxicity.Keywords
This publication has 42 references indexed in Scilit:
- Trimethoprim-SulfamethoxazoleNew England Journal of Medicine, 1980
- Trimethoprim resistance in Finland.BMJ, 1980
- Relevance of in vitro synergy to therapy: does synergy between diaminopyrimidines and sulphonamides operate at concentrations achievable in urine?Journal of Antimicrobial Chemotherapy, 1979
- Trimethoprim-Sulfamethoxazole in the Treatment of Gonococcal Urethritis: Clinical and Laboratory CorrelatesThe Journal of Infectious Diseases, 1973
- Effect of Trimethoprim on Folate Metabolism in Human Bone MarrowAustralian and New Zealand Journal of Medicine, 1973
- Trimethoprim in Normal and Pathological Human Lung TissueChemotherapy, 1973
- Kidney Transport in Man of Sulfamethoxazole and TrimethoprimChemotherapy, 1972
- Pharmacokinetics of Sulfamethoxazole + Trimethoprim in Man and Their Distribution in the RatChemotherapy, 1970
- Insulin antibodiesPostgraduate Medical Journal, 1969